Early-onset epilepsy and inborn errors of metabolism: A large retrospective pediatric cohort
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Inborn errors of metabolism (IEM) are an under-recognised cause of childhood epilepsy. Early diagnosis is critical because specific treatments can substantially alter the disease course. METHODS: We performed a retrospective study on 21,072 children evaluated for epilepsy in two Child Neurology referral centres in Eastern Sicily (i.e. Messina, Catania, and Enna) between January 2001 and December 2025. Medical records were reviewed to identify patients with a confirmed IEM diagnosis. Clinical, electrophysiological, neuroimaging, and treatment data were collected and analysed. RESULTS: Fifty-seven children (0.27%) had a co-diagnosis of epilepsy and IEM (28 males, 29 females). Lysosomal storage disorders were the most common category (31.6%), followed by aminoacidopathies (22.8%), mitochondrial disorders (15.8%), congenital disorders of glycosylation (CDG, 12.3%), and organic acidaemias (7.0%). Seizure onset occurred before the age of three years in 83.3% of IEM cases, compared with 27.6% of children with non-metabolic epilepsy (OR 12.3; 95% CI 6.2-24.4; p < 0.001). Diagnostic delay exceeded 3.5 years from first seizure in half the cohort. Approximately 50% of patients showed drug-resistant epilepsy despite multi-drug anti-seizure medication therapy. CONCLUSIONS: IEM should be systematically considered in any child presenting with epilepsy, particularly when onset occurs in the first three years of life. A structured stepwise diagnostic approach can substantially reduce diagnostic delay and facilitate access to disease-specific therapies.
Source: Epilepsy & Behavior
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Keywords: inborn errors of metabolism, early-onset epilepsy, pediatric epilepsy, lysosomal storage disease, amino acid metabolism disorders, mitochondrial disease, congenital disorders of glycosylation, organic aciduria, delayed diagnosis, drug-resistant epilepsy, seizure onset age, pediatric neurology
Open Access status: hybrid
Estimated APC paid: $3,060
OpenAlex ID: W7226034546
